CIRM Clinical Dashboard

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areassort ascending Investigator Organization Phase Trial Status Targeted Enrollment Detail
  • Multiple Myeloma
Matthew Spear Poseida Therapeutics, Inc. Phase 1 Closed 105
  • Leukemia, Acute Myeloid (AML)
Colleen Delaney Nohla Therapeutics Inc Phase 2 Closed 146
  • Leukemia, Acute Myeloid (AML)
Mark Chao Forty Seven Inc. Phase 1 Active, not recruiting 258
  • Leukemia, Acute Myeloid (AML)
Joseph Woodard Immune-Onc Therapeutics Phase 1 Recruiting 119
Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 10
Thomas Kipps University of California, San Diego Phase 1 Completed 26
Irving Weissman Stanford University Phase 1 Completed 88
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Active, not recruiting 60
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 42
Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 138
David Miklos Stanford University Phase 1 Recruiting 60
  • B cell cancers
  • Leukemia
  • Leukemia, Acute Myeloid (AML)
Maria Grazia Roncarolo Stanford University Phase 1 Recruiting 22
Icon for XLSX export